Citric acid
Citric acid is a weak organic acid used in various preparations; in combination products it acidifies the urine or, with potassium/sodium citrate, alkalinises it, and it is also used to dissolve catheter encrustation as a bladder irrigation.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It acts as a buffering agent and, depending on the salt with which it is combined, modifies urinary pH; as a chelating irrigation it helps dissolve calcium and struvite deposits.
Prescribing in practice
- Confirm the intended preparation and indication, as citric acid appears in many different formulations (oral acidifying mixtures, alkalinising citrate salts, and bladder irrigations) that are not interchangeable.
- Oral citrate combinations contain sodium or potassium and should be used cautiously where there is cardiac, renal or electrolyte concern; check the SPC for the specific product.
- Avoid concomitant use that would inappropriately alter urinary pH against the therapeutic aim and review interacting medicines whose elimination is pH-dependent.
Monitoring
Monitor urinary pH where the aim is to acidify or alkalinise, and check serum electrolytes when sodium- or potassium-containing citrate preparations are used.
Counselling the patient
- Take oral preparations diluted in water as directed.
- Report any swelling, breathlessness or palpitations promptly.
- Use the specific product prescribed and do not substitute.
Evidence & guidelines
Use is long established and reflected in current prescribing references and the relevant SPCs rather than in large randomised trials.
Reference: Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Harvey-Bradshaw Index for Crohn's Disease · Inflammatory Bowel Disease
- Mayo Score for Ulcerative Colitis Activity · Inflammatory Bowel Disease
- Rome IV Criteria for Irritable Bowel Syndrome · Functional GI
- Crohn's Disease Activity Index (CDAI) · Inflammatory Bowel Disease
- Truelove and Witts Severity Index for Ulcerative Colitis · Inflammatory Bowel Disease
- Ulcerative Colitis Endoscopic Index of Severity (UCEIS) · Inflammatory Bowel Disease
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021